Patent Assignment
Reel/Frame 029150/0303
Change of Name
Recorded: 2012-10-18
Pages: 175
Assignor
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Executed: 2012-08-24
Assignee
BAYER PHARMA AG
MUELLERSTRASSE 178, BERLIN, 13353, GERMANY
Covered Properties
(21)
Regulation of Human Transmembrane Serine Protease
Corin, a Serine Protease
Patent:
6,806,075 →
Application:
09/959,392 →
Regulation of Human Prostasin-Like Serine Protease
Sustained-Release Preparations of Quinolone Antibiotics and Method for Preparation Thereof
Regulation of Human Adenylate Cyclase
Regulation of Human Aminopeptidase N
Acylglycerol Acyltransferase-Like Protein Mgat-X1 and Uses Thereof
Regulation of Human Ceramide Kinase
Regulation of Human Transmembrane Serine Protease
Regulation of Human Caspase-1-Like Protease
Regulation of Human Prostasin-Like Serine Protease
Method of Preparing Sustained-Release Preparations of Quinolone Antibiotics
Sustained-Release Preparations of Quinolone Antibiotics
Polynucleotides Encoding Anticoagulant Fusion Proteins
Methods of Using Novel Tissue Factor Targeted Thrombomodulin Fusion Proteins as Anticoagulants
Regulation of Human Transmembrane Serine Protease
LTBP2 as a Biomarker and Diagnostic Target
PRSS23 as a Biomarker and Diagnostic Target
Application:
12/445,494 →
Publication:
US 2010/0104501
Monospecific and Multispecific Antibodies and Method of Use
Antibodies to TNF Alpha
Acylglycerol Acyltransferase-Like Protein Mgat-X1 and Uses Thereof
Related Assignments
(1)
Other recorded transfers of the patents in this record — the chain of ownership.